Topics

FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia

20:00 EDT 25 Mar 2020 | Cancer Networks

The FDA has approved a phase III clinical trial to assess the safety and efficacy of intravenous tocilizumab (Actemra) plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia.

Original Article: FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...